Silver Book Fact

Healthcare costs of atrial fibrillation

Atrial fibrillation (AF) is a major economic burden for society with the biggest cost driver being hospitalizations—accounting for 52% of costs. Drugs for AF account for 23% of costs, consultations at 9%, further investigations at 8%, loss of work at 6%, and paramedical procedures at 2%.

Le Heuzey J, Paziaud O, Piot O, Ait S, et al. Cost of Care Distribution in Atrial Fibrillation Patients: The COCAF study. Am Heart J. 2004; 147(1): 121-6. https://pubmed.ncbi.nlm.nih.gov/14691429/

Reference

Title
Cost of Care Distribution in Atrial Fibrillation Patients: The COCAF study
Publication
Am Heart J
Publication Date
2004
Authors
Le Heuzey J, Paziaud O, Piot O, Ait S, et al.
Volume & Issue
Volume 147, Issue 1
Pages
121-6
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • Atrial Fibrillation prevalence increase from 1992 to 2002
    Among Medicare patients ages 65 and older, atrial fibrillation prevalence increased from 3.2% in 1992 to 6.0% in 2002–with higher prevalence in older patients.  
  • Atrial fibrillation doubles mortality risk
    Atrial fibrillation is associated with an approximate doubling of mortality risk.  
  • Hospital readmission rates among AFib patients
    In the year following initial hospitalization for atrial fibrillation (AF), 12.5% of chronic AF patients were readmitted for AF—17.6% of readmissions occurred within 1 month. Among newly-diagnosed patients, 10.1% were…  
  • Annual AFib-related stroke Medicare costs
    Stroke in Medicare patients with atrial fibrillation who were not treated with anticoagulants, cost Medicare $4.8 billion each year in direct costs. Those who had strokes despite prophylactic treatment cost an additional…  
  • One-Year Cost Component for Atrial Fibrillation & Non AF Medicare Patients
    One-Year Cost Component for AF & Non AF Medicare Patients